Blue Owl Capital Holdings LP Ultragenyx Pharmaceutical Inc. Transaction History
Blue Owl Capital Holdings LP
- $303 Million
- Q3 2024
A detailed history of Blue Owl Capital Holdings LP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Blue Owl Capital Holdings LP holds 163,238 shares of RARE stock, worth $7.02 Million. This represents 2.99% of its overall portfolio holdings.
Number of Shares
163,238
Previous 268,238
39.14%
Holding current value
$7.02 Million
Previous $11 Million
17.75%
% of portfolio
2.99%
Previous 4.58%
Shares
3 transactions
Others Institutions Holding RARE
# of Institutions
326Shares Held
85.7MCall Options Held
520KPut Options Held
406K-
Vanguard Group Inc Valley Forge, PA9.95MShares$428 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$241 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.12MShares$220 Million0.91% of portfolio
-
Wellington Management Group LLP Boston, MA4.17MShares$179 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.07MShares$132 Million0.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.01B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...